Xencor Initiates Phase I Clinical Trial with XmAb2513 in Lymphoma

News   Feb 12, 2008

 
Xencor Initiates Phase I Clinical Trial with XmAb2513 in Lymphoma
 
 
 

RELATED ARTICLES

PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

News

Will shorten timelines, reduce costs and simplify contracting process in pediatric programs.

READ MORE

Proteasome Blocker Brings Glaucoma Gene Therapy Closer

News

An enhanced gene therapy technique that pairs a viral vector with a proteasome blockade has doubled the therapy's efficiency.

READ MORE

Dietary Fat Metabolism May Promote Metastasis

News

A new study has highlighted links between dietary fat and prostate cancer, suggesting a high-fat Western diet may encourage tumour metastasis.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE